Ishares Msci Brazil ETF vs Mesoblast Limited — how do they compare? Ishares Msci Brazil ETF trades at $34.19, while Mesoblast Limited trades at $16.96 (market cap $2.21B). Which is the better fit depends on your goals.
| EWZ | MESO | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $41.75 | $20.96 |
52-Week Low | $27.36 | $12.88 |
Market Cap | — | $2.21B |
Enterprise Value | — | $2.21B |
Trailing returns across standard periods
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →